Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`
Open accessAbstract
Cognitive deficits in depression can be modelled using the novel object recognition (NOR) test, performance in which is impaired by chronic mild stress (CMS). We aimed to examine the involvement of mesocorticolimbic DA terminal regions, and to establish the substrate for CMS-induced impairment of NOR and its reversal by chronic antidepressant treatment. In experiments 1 and 2, we examined the effect of infusions into medial PFC, dorsal hippocampus (HPC), and nucleus accumbens (NAc) shell of D1 and D2 antagonists and D3 agonist, which were predicted to impair NOR with a short (1 h) delay, and of D1 and D2 agonists and D3 antagonist, which were predicted to facilitate NOR with a long (24 h) delay. Using optimal doses identified in experiment 2, in experiments 3 and 4, we examined effects on drug-stimulated NOR of CMS and chronic treatment with venlafaxine (VFX) or risperidone (RSP). We found a wide involvement of DA systems in memory for NOR: D1 receptors in PFC, HPC, and NAc; D3 receptors in PFC and HPC; and D2 receptors in PFC. CMS impaired D2- and D3-mediated effects in PFC and HPC; antidepressants rescued those effects in PFC but not HPC. The involvement of DA in NOR is multifaceted, but the effects of CMS and antidepressants are more discrete, involving D2 and D3 receptors in PFC specifically. While raising many difficult questions, these results suggest that the D2 and D3 receptors in the medial PFC may be an important substrate for cognitive deficits in depression and their remediation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Post-sample microinjections of the D1-R agonist SKF81297, the D2-R agonist quinpirole or the D3-R antagonist SB277,011 into the PFC facilitated NOP memory when tested after 24 hours.
“Conversely, post-sample microinjections of the D1-R agonist SKF81297, the D2-R agonist quinpirole or the D3-R antagonist SB277,011 into the PFC facilitated NOP memory when tested after 24 hours (Papp et al., 2017).”
From The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties (2020) · cites this paper as Papp et al., 2017
Post-sample microinjections of the D1-R antagonist SCH23390, the D2-R antagonist L-741.626 or the D3-R agonist 7-OH-DPAT into the PFC dose-dependently impaired NOP memory when tested 1 hour later.
“Microinjections of the D1-R antagonist SCH23390, the D2-R antagonist L-741.626 or the D3-R agonist 7-OH-DPAT into the PFC after the sample trial dose-dependently impaired NOP memory when tested 1 hour later (Papp et al., 2017).”
From The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties (2020) · cites this paper as Papp et al., 2017
Post-sample microinjections of the D1-R agonist SKF81297, the D2-R agonist quinpirole and the D3-R antagonist SB277,011 into the dorsal hippocampus facilitated NOP when tested after 24 hours.
“Post-sample microinjections of the D1-R agonist SKF81297, the D2-R agonist quinpirole and the D3-R antagonist SB277,011 into the dorsal hippocampus facilitated NOP when tested after 24 hours”
From The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties (2020) · cites this paper as Papp et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data
Ennaceur, A., & Delacour, J. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90157-x · Cited by 3,223 · see citing works
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · see citing works
Neurobiology of emotion perception II: implications for major psychiatric disorders
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00171-9 · Cited by 1,736 · see citing works
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · see citing works
Cognitive deficits in depression: Possible implications for functional neuropathology
Austin, M.-P., Mitchell, P., & Goodwin, G. M. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.200 · Cited by 1,154 · see citing works
The chronic mild stress (CMS) model of depression: History, evaluation and usage
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.002 · Cited by 959 · see citing works
Lévesque, D., Díaz, J., Pilon, C., Martres, M., Bruno Giros, A., Souil, E., Schott, D., Morgat, J. L., Schwartz, J., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674 · see citing works
Kempadoo, K. A., Mosharov, E. V., Choi, S. J., Sulzer, D., & Kandel, E. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616515114 · Cited by 647 · see citing works
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Díaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 573 · see citing works
Neurobiology of Decision Making: A Selective Review from a Neurocognitive and Clinical Perspective
Monique Ernst, D., & Paulus, M. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.004 · Cited by 567 · see citing works
Targeted electrode-based modulation of neural circuits for depression.
Mayberg, H. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38454 · Cited by 542 · see citing works
Brisch, R., Saniotis, A., Wolf, R. J., Bielau, H., Bernstein, H., Steiner, J. H., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00047 · Cited by 520 · see citing works
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519 · see citing works
Self-citationThe subcallosal cingulate gyrus in the context of major depression
Hamani, C., Mayberg, H., Stone, S., Laxton, A., Haber, S., & Lozano, A. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.034 · Cited by 508 · see citing works
Chudasama, Y., & Robbins, T. W. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.005 · Cited by 484 · see citing works
Seamans, J. K., Floresco, S., & Phillips, A. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01613.1998 · Cited by 472 · see citing works
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
Floresco, S. B., Magyar, O., Ghods-Sharifi, S., Vexelman, C., & Tse, M. T. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300825 · Cited by 395 · see citing works
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study
Zarate, C. A., Payne, J. L., Singh, J. B., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.013 · Cited by 342 · see citing works
Reavill, C., Taylor, S. G., Wood, M. D., Ashmeade, T., Austin, N. E., Avenell, K. Y., Boyfield, I., Branch, C. L., Cilia, J., Coldwell, M. C., et al. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39184-0 · Cited by 287 · see citing works
Chiara, G. D., Loddo, P., & Tanda, G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00236-x · Cited by 266 · see citing works
An excitatory synapse hypothesis of depression
Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.03.003 · Cited by 265 · see citing works
Spine synapse remodeling in the pathophysiology and treatment of depression
Duman, C. H., & Duman, R. S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.022 · Cited by 257 · see citing works
Cellular and molecular basis for stress-induced depression
Seo, J.-S., Wei, J., Qin, L., Kim, Y., Yan, Z., & Greengard, P. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.118 · Cited by 235 · see citing works
The dopamine D3 receptor, a quarter century later
Sokoloff, P., & Foll, B. L. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13390 · Cited by 223 · see citing works
The mesolimbic dopamine system as a target for rapid antidepressant action
Willner, P. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707003-00002 · Cited by 209 · see citing works
Durgam, S., Earley, W., Lipschitz, A., Guo, H., Laszlovszky, I., Németh, G., Vieta, E., Calabrese, J. R., & Yatham, L. N. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020164 · Cited by 209 · see citing works
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS
Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016) · Depression and Anxiety · doi:10.1002/da.22501 · Cited by 206 · see citing works
Papp, M., Klimek, V., & Willner, P. (1994) · Psychopharmacology · doi:10.1007/bf02245566 · Cited by 202 · see citing works
Elizalde, N., Gil-Bea, F. J., Ramírez, M. J., Aisa, B., Lasheras, B., del Rı́o, J. A., & Tordera, R. M. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1035-1 · Cited by 195 · see citing works
Evans, V. C., Iverson, G. L., Yatham, L. N., & Lam, R. W. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08939 · Cited by 185 · see citing works
Nagai, T., Takuma, K., Kamei, H., Ito, Y., Nakamichi, N., Ibi, D., Nakanishi, Y., Murai, M., Mizoguchi, H., Nabeshima, T., et al. (2007) · Learning & Memory · doi:10.1101/lm.461407 · Cited by 184 · see citing works
Depression: from psychopathology to pathophysiology
Belzung, C., Willner, P., & Philippot, P. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.08.013 · Cited by 179 · see citing works
The potential role of dopamine D3 receptor neurotransmission in cognition
Nakajima, S., Gerretsen, P., Takeuchi, H., Caravaggio, F., Chow, T. W., Foll, B. L., Mulsant, B. H., Pollock, B. G., & Graff‐Guerrero, A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.006 · Cited by 179 · see citing works
Pezze, M.-A., Dalley, J. W., & Robbins, T. W. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301073 · Cited by 170 · see citing works
Dopaminergic mechanism of antidepressant action in depressed patients
Willner, P., Hale, A. S., & Argyropoulos, S. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.010 · Cited by 169 · see citing works
Kamei, H., Nagai, T., Nakano, H., Togan, Y., Takayanagi, M., Takahashi, K., Kobayashi, K., Yoshida, S., Maeda, K., Takuma, K., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.006 · Cited by 165 · see citing works
Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats
Wilkerson, A., & Levin, E. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00346-7 · Cited by 160 · see citing works
Dopamine D2-Like Receptors and the Antidepressant Response
Gershon, A. A., Vishne, T. H., & Grunhaus, L. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.031 · Cited by 159 · see citing works
Lammers, C.-H., Díaz, J., Jc, S., & Sokoloff, P. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000754 · Cited by 155 · see citing works
Watson, D. J., Loiseau, F., Ingallinesi, M., Millan, M. J., Marsden, C. A., & Fone, K. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.254 · Cited by 151 · see citing works
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
Wohleb, E. S., Gerhard, D. M., Thomas, A., & Duman, R. S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160309114549 · Cited by 151 · see citing works
Lucas, L., Celen, Z., Tamashiro, K. L., Blanchard, R. J., Blanchard, D. C., Markham, C. M., Sakai, R. R., & McEwen, B. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.009 · Cited by 145 · see citing works
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia
Arnsten, A., Girgis, R. R., Gray, D. L., & Mailman, R. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.028 · Cited by 144 · see citing works
Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole
Willner, P., Lappas, S., Cheeta, S., & Muscat, R. (1994) · Psychopharmacology · doi:10.1007/bf02245568 · Cited by 142 · see citing works
Jay, T. M., Rocher, C., Hotte, M., Naudon, L., Gurden, H., & Spedding, M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033225 · Cited by 141 · see citing works
Prefrontal dopamine in associative learning and memory
Puig, M. V., Antzoulatos, E. G., & Miller, E. K. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.026 · Cited by 138 · see citing works
Millan, M. J., Cara, B. D., Dekeyne, A., Panayi, F., de Groote, L., Sicard, D., Cistarelli, L., Billiras, R., & Gobert, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04262.x · Cited by 125 · see citing works
Klimke, A. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00009-8 · Cited by 125 · see citing works
Lindström, L., Lindström, E., Nilsson, M., & Höistad, M. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.012 · Cited by 122 · see citing works
ŞAHİN, T. D., Karson, A., Balcı, F., Yazır, Y., Bayramgürler, D., & Utkan, T. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.062 · Cited by 119 · see citing works
Antidepressant-like effects of dopamine agonists in an animal model of depression
Muscat, R., Papp, M., & Willner, P. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90119-k · Cited by 119 · see citing works
Hersi, A. I., Rowe, W. B., Gaudreau, P., & Quirion, R. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00319-e · Cited by 119 · see citing works
Millan, M. J., Dekeyne, A., Papp, M., Rochelle, C. D. L., MacSweeny, C., Péglion, J.-L., & Brocco, M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29416-7 · Cited by 117 · see citing works
Reversal of antidepressant action by dopamine antagonists in an animal model of depression
Sampson, D., Willner, P., & Muscat, R. (1991) · Psychopharmacology · doi:10.1007/bf02245655 · Cited by 115 · see citing works
Object recognition testing: Statistical considerations
Akkerman, S., Prickaerts, J., Steinbusch, H. W. M., & Blokland, A. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.024 · Cited by 114 · see citing works
Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107 · see citing works
Larisch, R., Klimke, A., Vosberg, H., Löffler, S., Gäebel, W., & Müller-Gärtner, H.-W. (1997) · NeuroImage · doi:10.1006/nimg.1997.0267 · Cited by 106 · see citing works
Lyon, L., Saksida, L. M., & Bussey, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2536-5 · Cited by 105 · see citing works
Modulatory influence of dopamine receptors on consolidation of object recognition memory
de Lima, M. N. M., Presti-Torres, J., Dornelles, A. D. S., Scalco, F. S., Roesler, R., Garcia, V. A., & Schröder, N. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.12.007 · Cited by 102 · see citing works
Llorente, R., Miguel-Blanco, C., Aisa, B., Lachize, S., Borcel, É., Meijer, O. C., Ramírez, M. J., de Kloet, E. R., & Viveros, M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02109.x · Cited by 101 · see citing works
Pramipexole in treatment-resistant depression: An extended follow-up
Cassano, P., Lattanzi, L., Soldani, F., Navari, S., Battistini, G., Gemignani, A., & Cassano, G. B. (2004) · Depression and Anxiety · doi:10.1002/da.20038 · Cited by 101 · see citing works
Dziedzicka‐Wasylewska, M., Willner, P., & Papp, M. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00017 · Cited by 101 · see citing works
Neill, J. C., Grayson, B., Kiss, B., Gyertyán, I., FERGUSON, P. W., & Adham, N. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.016 · Cited by 93 · see citing works
D1/D5 dopamine receptors modulate spatial memory formation
da Silva, W. C. N., Köhler, C. A., Radiske, A., & Cammarota, M. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.01.005 · Cited by 92 · see citing works
Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats
Hotte, M., Naudon, L., & Jay, T. M. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.04.002 · Cited by 89 · see citing works
Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats
Liu, D., Zhang, Q., Gu, J., Wang, X., Xie, K., Xian, X., Wang, J., Jiang, H., & Wang, Z. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.017 · Cited by 87 · see citing works
Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain
Maj, J., Dziedzicka‐Wasylewska, M., Rogoż, R., & Rogóż, Z. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00297-0 · Cited by 85 · see citing works
Wright, B. M., Eiland, E. H., & Lorenz, R. A. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1204 · Cited by 84 · see citing works
Brown, M. W., Barker, G. R. I., Aggleton, J. P., & Warburton, E. C. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.07.034 · Cited by 84 · see citing works
Watson, D. J., Marsden, C. A., Millan, M. J., & Fone, K. C. F. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000435 · Cited by 81 · see citing works
Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression
Papp, M., Gruca, P., Łasoń, M., Adham, N., Kiss, B., & Gyertyán, I. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000070 · Cited by 80 · see citing works
Functional Significance of Central D1 Receptors in Cognition: Beyond Working Memory
Takahashi, H., Yamada, M., & Suhara, T. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.194 · Cited by 79 · see citing works
Xing, B., Kong, H., Meng, X., Wei, S., Xu, M., & Li, S. B. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.034 · Cited by 78 · see citing works
Dopamine vs Noradrenaline: Inverted-U Effects and ADHD Theories
Lévy, F. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802607238 · Cited by 77 · see citing works
Hotte, M., Thuault, S., Lachaise, F., Dineley, K. T., Hemmings, H. C., Nairn, A. C., & Jay, T. M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.026 · Cited by 76 · see citing works
Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls
Bowden, C., Theodorou, A. E., Cheetham, S. C., Lowther, S., Katona, C., Crompton, M. R., & Horton, R. W. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01460-6 · Cited by 76 · see citing works
Brain monoamine receptors in a chronic unpredictable stress model in rats
Ossowska, G., Nowak, G., Kata, R., Klenk-Majewska, B., Danilczuk, Z., & Żebrowska-Łupina, I. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170077 · Cited by 76 · see citing works
Increased vulnerability to cocaine in mice lacking dopamine D 3 receptors
Song, R., Zhang, H., Li, X., Bi, G., Gardner, E. L., & Xi, Z. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205297109 · Cited by 76 · see citing works
Rossato, J. I., Radiske, A., Kohler, C. A., Gonzalez, C., Bevilaqua, L. R., Medina, J. H., & Cammarota, M. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.07.012 · Cited by 75 · see citing works
Darvas, M., & Palmiter, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907299106 · Cited by 75 · see citing works
Czubak, A., Nowakowska, E., Kus, K., Burda, K., Metelska, J., Baer‐Dubowska, W., & Cichocki, M. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70163-x · Cited by 71 · see citing works
Millan, M. J., Buccafusco, J. J., Loiseau, F., Watson, D. J., Decamp, E., Fone, K. C. F., Thomasson, N., Hill, M. P., Mocaër, E., & Schneider, J. S. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000775 · Cited by 70 · see citing works
Loiseau, F., & Millan, M. J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.012 · Cited by 69 · see citing works
D’Aquila, P. S., Monleón, S., Borsini, F., Brain, P. F., & Willner, P. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01412-x · Cited by 69 · see citing works
Miskowiak, K. W., Ott, C. V., Petersen, J. Z., & Kessing, L. V. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.09.641 · Cited by 69 · see citing works
Gu, H., Nie, Y., Tong, Q., Tang, Y., Zeng, Y., Jing, K.-Q., Zheng, X., & Liao, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112683 · Cited by 68 · see citing works
Papp, M., Gruca, P., Łasoń, M., & Willner, P. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4206-0 · Cited by 68 · see citing works
Arnt, J., Hyttel, J., & Meier, E. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90400-1 · Cited by 65 · see citing works
Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice
Foll, B. L., Díaz, J., & Sokoloff, P. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.09.018 · Cited by 63 · see citing works
Watson, D. J., King, M. V., Gyertyán, I., Kiss, B., Adham, N., & Fone, K. C. F. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.020 · Cited by 63 · see citing works
Papp, M., Gruca, P., Łasoń, M., & Willner, P. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000259 · Cited by 63 · see citing works
Models of Affective Illness: Chronic Mild Stress in the Rat
Papp, M. (2012) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0509s57 · Cited by 61 · see citing works
D1 and D5 dopamine receptors participate on the consolidation of two different memories
Furini, C. R. G., Myskiw, J. C., Schmidt, B. E., Marcondes, L. A., & Izquierdo, I. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.027 · Cited by 60 · see citing works
Orsetti, M., Colella, L., Dellarole, A., Canonico, P. L., & Ghi, P. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006705 · Cited by 60 · see citing works
The effects of social defeat on behavior and dopaminergic markers in mice
Jin, H.-M., Muna, S. S., Bagalkot, T. R., Cui, Y., Yadav, B. K., & Chung, Y. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.043 · Cited by 59 · see citing works
Consolidation and reconsolidation of object recognition memory
Balderas, I., Rodríguez‐Ortiz, C. J., & Bermúdez‐Rattoni, F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.049 · Cited by 58 · see citing works
Mood disorders: neurocognitive models
Malhi, G. S., Byrow, Y., Fritz, K., Das, P., Baune, B. T., Porter, R., & Outhred, T. (2015) · Bipolar Disorders · doi:10.1111/bdi.12353 · Cited by 58 · see citing works
Weikop, P., Kehr, J., & Scheel-Krüger, J. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800311 · Cited by 57 · see citing works
Scheggi, S., Leggio, B., Masi, F., Grappi, S., Gambarana, C., Nanni, G., Rauggi, R., & Montis, M. G. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01193.x · Cited by 53 · see citing works
Cognitive functioning in depression: a review of theory and research
Willner, P. (1984) · Psychological Medicine · doi:10.1017/s0033291700019784 · Cited by 52 · see citing works
Nelson, A. J. D., Thur, K. E., Marsden, C. A., & Cassaday, H. J. (2010) · Behavioral Neuroscience · doi:10.1037/a0021114 · Cited by 50 · see citing works
Riaz, M. S., Bohlen, M. O., Gunter, B. W., Henry, Q., Stockmeier, C. A., & Paul, I. A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.09.005 · Cited by 49 · see citing works
Sokoloff, P., Leriche, L., Díaz, J., Louvel, J., & Pumain, R. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0797-0 · Cited by 47 · see citing works
Castro‐Hernández, J., Afonso‐Oramas, D., Cruz‐Muros, I., Salas-Hernández, J., Barroso‐Chinea, P., Moratalla, R., Millan, M. J., & González‐Hernández, T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.007 · Cited by 47 · see citing works
Fujishiro, H., Umegaki, H., Suzuki, Y., Kurotani, S., Yamaguchi, Y., & Iguchi, A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0072-x · Cited by 47 · see citing works
Bristow, L. J., Cook, G. P., Patel, S. S., Curtis, N. R., Mawer, I. M., & Kulagowski, J. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00066-5 · Cited by 45 · see citing works
D2 dopamine receptor regulation of learning, sleep and plasticity
França, A. S. C., Soares, B. L., Muratori, L., Nascimento, G., Winne, J., Pereira, C. M., Jerônimo, S. M. B., & Ribeiro, S. T. G. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.011 · Cited by 43 · see citing works
Cuadrado‐Tejedor, M., Ricobaraza, A., Río, J. D., Frechilla, D., Franco, R., Pérez‐Mediavilla, A., & García‐Osta, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.005 · Cited by 42 · see citing works
Lokhandwala, M. F., & Steenberg, M. L. (1984) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1984.tb00105.x · Cited by 41 · see citing works
Cardoso-Cruz, H., Dourado, M., Monteiro, C., Matos, M. R., & Galhardo, V. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0021-14.2014 · Cited by 39 · see citing works
De Bundel, D., Femenía, T., DuPont, C. M., Konradsson-Geuken, Å., Feltmann, K., Schilström, B., & Lindskog, M. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000370 · Cited by 37 · see citing works
Leggio, G. M., Micale, V., & Drago, F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.07.003 · Cited by 37 · see citing works
Elevated Aggression and Reduced White Matter Integrity in Mild Traumatic Brain Injury: A DTI Study
Dailey, N. S., Smith, R. S., Bajaj, S., Alkozei, A., Gottschlich, M., Raikes, A. C., Satterfield, B. C., & Killgore, W. D. S. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00118 · Cited by 35 · see citing works
Huang, X., Mao, Y.-S., Li, C., Wang, H., & Jian-lin, J. (2014) · Die Pharmazie · doi:10.31083/ph.2014.4661 · Cited by 33 · see citing works
D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV
Braszko, J. J. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.03.025 · Cited by 32 · see citing works
Barth, V., Need, A. B., Tzavara, E. T., Bruno Giros, A., Overshiner, C. D., Gleason, S. D., Wade, M. R., Johansson, A., Perry, K. W., Nomikos, G. G., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198895 · Cited by 32 · see citing works
Impact of Untreated Major Depressive Disorder on Cognition and Daily Function
Culpepper, L. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13086tx4c · Cited by 30 · see citing works
Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice
Xing, B., Liu, P., Jiang, W., Liu, F., Zhang, H., Cao, G., Chen, T., & Dang, Y. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.019 · Cited by 29 · see citing works
Marston, H. M., Martin, F., Papp, M., Gold, L. H., Wong, E. H. F., & Shahid, M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110376684 · Cited by 27 · see citing works
Cussac, D., Pasteau, V., & Millan, M. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.077 · Cited by 24 · see citing works
Lejeune, S., Dourmap, N., Martres, M., Bruno Giros, A., Daugé, V., & Naudon, L. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.10.005 · Cited by 23 · see citing works
Sun, X., Gou, H., Li, F. R., Lu, G.-Y., Song, R., Yang, R., Wu, N., Su, R., Cong, B., & Li, J. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.105 · Cited by 22 · see citing works
Antidepressants and Their Effect on Cognition in Major Depressive Disorder
Papakostas, G. I. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13086tx5c · Cited by 19 · see citing works
Dopamine D1 receptor modulation of set shifting
Nikiforuk, A. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328356522f · Cited by 17 · see citing works
Dopamine D3 Receptor Mediates Preadolescent Stress-Induced Adult Psychiatric Disorders
Seo, J. H., & Kuzhikandathil, E. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143908 · Cited by 14 · see citing works
Object recognition impairment and rescue by a dopamine D2 antagonist in hyperdopaminergic mice
França, A. S. C., Muratori, L., Nascimento, G., Pereira, C. M., Ribeiro, S. T. G., & Soares, B. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.04.009 · Cited by 14 · see citing works
Regulation of ethanol intake under chronic mild stress: roles of dopamine receptors and transporters
Delis, F., Rombola, C., Bellezza, R., Rosko, L. M., Grandy, D. K., Volkow, N. D., & Thanos, P. K. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00118 · Cited by 13 · see citing works
The influence of antidepressants on aggressive behavior in stressed rats: the role of dopamine.
Zebrowska-Łupina, I., Ossowska, G., & Klenk-Majewska, B. (1993) · PubMed · Cited by 10 · see citing works
The touchscreen operant platform for assessing cognitive functions in a rat model of depression
Tran, T. P., Christensen, H. L., Bertelsen, F., Bouzinova, E. V., Møller, A., & Wiborg, O. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.03.032 · Cited by 9 · see citing works
[Effect of Risperidone on BDNF-TrkB Signaling Pathway in Rat Brain].
Yu, B., Wang, X., Wei, J., Ni, P.-Y., Liang, L.-H., Zhao, L., Ma, X., Li, T., & Wang, Y. (2015) · PubMed · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Antoniuk, S., Bijata, M., Ponimaskin, E., & Wlodarczyk, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.002 · Cited by 750 · see citing works
Chao, O. Y., de Souza Silva, M. A., Yang, Y.-M., & Huston, J. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.007 · Cited by 158 · see citing works
Willner, P., Gruca, P., Łasoń, M., Tota-Glowczyk, K., Litwa, E., Niemczyk, M., & Papp, M. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000431 · Cited by 88 · see citing works
Kiss, B., Laszlovszky, I., Krámos, B., Visegrády, A., Bobok, A. Á., Lévay, G. I., Lendvai, B., & Román, V. (2021) · Biomolecules · doi:10.3390/biom11010104 · Cited by 74 · see citing works
Zhu, M., Liu, Z.-J., Hu, Q.-Y., Yang, J., Jin, Y., Zhu, N., Huang, Y., Shi, D.-H., Liu, M.-J., Tan, H.-Y., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00420-0 · Cited by 65 · see citing works
Papp, M., Gruca, P., Łasoń, M., Tota-Glowczyk, K., Niemczyk, M., Litwa, E., & Willner, P. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118791737 · Cited by 40 · see citing works
Models of Affective Illness: Chronic Mild Stress in the Rat
Papp, M., & Willner, P. (2023) · Current Protocols · doi:10.1002/cpz1.712 · Cited by 36 · see citing works
Depoortère, R., Papp, M., Gruca, P., Łasoń, M., Niemczyk, M., Varney, M. A., & Newman‐Tancredi, A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119860666 · Cited by 33 · see citing works
Mohamed, A. M., Habib, M. Z., Ebeid, M. A., Abdelraouf, S. M., el Faramawy, Y., Aboul‐Fotouh, S., & Magdy, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173411 · Cited by 33 · see citing works
Kim, H. R., Lee, Y.-J., Kim, T.-W., Lim, R.-N., Hwang, D. Y., Moffat, J. J., Kim, S., Seo, J., & Ka, M. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03121-0 · Cited by 32 · see citing works
Bakhtiari-Dovvombaygi, H., Izadi, S., Zare, M., Hasanluyi, E. A., Dinpanah, H., Ahmadi‐Soleimani, S. M., & Beheshti, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-95850-6 · Cited by 32 · see citing works
Wigner, P., Synowiec, E., Czarny, P. L., Bijak, M., Jóźwiak, P., Szemraj, J., Gruca, P., Papp, M., & Śliwiński, T. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15231 · Cited by 30 · see citing works
Papp, M., Gruca, P., Łasoń, M., Niemczyk, M., & Willner, P. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119827889 · Cited by 25 · see citing works
Haduch, A., Rysz, M. A., Papp, M., & Daniel, W. A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.005 · Cited by 25 · see citing works
Flores‐Burgess, A., Millón, C., Gago, B., García-Durán, L., Cantero-García, N., Coveñas, R., Narváez, J. Á., Fuxé, K., Santín, L. J., & Dı́az-Cabiale, Z. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.023 · Cited by 23 · see citing works
Wigner, P., Synowiec, E., Jóźwiak, P., Czarny, P. L., Bijak, M., Białek, K. I., Szemraj, J., Gruca, P., Papp, M., & Śliwiński, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010010 · Cited by 21 · see citing works
Papp, M., Gruca, P., Łasoń, M., Litwa, E., Solecki, W., & Willner, P. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120967857 · Cited by 21 · see citing works
Papp, M., Gruca, P., Faron‐Górecka, A., Kuśmider, M., & Willner, P. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.015 · Cited by 17 · see citing works
Anti-stress Properties of Atypical Antipsychotics
Sanson, A., & Riva, M. A. (2020) · Pharmaceuticals · doi:10.3390/ph13100322 · Cited by 17 · see citing works
Białek, K. I., Czarny, P. L., Wigner, P., Synowiec, E., Barszczewska-Pietraszek, G., Bijak, M., Szemraj, J., Niemczyk, M., Tota-Glowczyk, K., Papp, M., et al. (2021) · Genes · doi:10.3390/genes12050667 · Cited by 14 · see citing works
Weber, S. J., Kawa, A. B., Beutler, M. M., Kuhn, H. M., Moutier, A. L., Westlake, J. G., Koyshman, L. M., Moreno, C. D., Wunsch, A. M., & Wolf, M. E. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01992-2 · Cited by 14 · see citing works
Cognitive dysfunction in mice lacking proper glucocorticoid receptor dimerization
Looveren, K. V., Boxelaere, M. V., Callaerts‐Vegh, Z., & Libert, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226753 · Cited by 14 · see citing works
Cabanu, S., Pilar-Cuéllar, F., Zubakina, P., Florensa-Zanuy, E., Senserrich, J., Newman‐Tancredi, A., & Adell, A. (2022) · Pharmaceuticals · doi:10.3390/ph15030337 · Cited by 14 · see citing works
Papp, M., Gruca, P., Łasoń, M., Litwa, E., Solecki, W., & Willner, P. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211048281 · Cited by 14 · see citing works
Browne, C. A., Smith, T., & Lucki, I. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172948 · Cited by 13 · see citing works
Papp, M., Gruca, P., Łasoń, M., Litwa, E., Newman‐Tancredi, A., & Depoortère, R. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06389-5 · Cited by 13 · see citing works
Papp, M., Gruca, P., Łasoń, M., Niemczyk, M., & Willner, P. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000483 · Cited by 11 · see citing works
Martis, L., Brision, C., Holmes, M. C., & Wiborg, O. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.08.014 · Cited by 13 · see citing works
Ahmed, A. S., Mona, M. M., Elsisy, R. A., & Hantash, E. M. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00433-y · Cited by 10 · see citing works
Shi, X., Barr, J. L., von Weltin, E., Wolsh, C. C., & Unterwald, E. M. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259283 · Cited by 9 · see citing works
Wigner, P., Synowiec, E., Jóźwiak, P., Czarny, P. L., Bijak, M., Białek, K. I., Szemraj, J., Gruca, P., Papp, M., & Śliwiński, T. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01563-2 · Cited by 9 · see citing works
Moghimian, M., Azin, S., Alavi-Kakhki, S. S., Kourosh‐Arami, M., Gholami, M., Beheshti, F., & Fani, M. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2145423 · Cited by 7 · see citing works
Ma, J.-C., Che, X., Zhu, X.-N., Ren, A.-X., Hu, Y., Yang, C.-L., Xu, Z.-T., Li, Y., Wu, C., & Yang, J. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01321-9 · Cited by 2 · see citing works
Thomas, M. E. (2020) · Preprints.org · doi:10.20944/preprints202007.0003.v1 · Cited by 2 · see citing works
Papp, M., Gruca, P., Łasoń, M., Litwa, E., Niemczyk, M., Tota-Glowczyk, K., Faron‐Górecka, A., Kuśmider, M., Solich, J., Szlachta, M., et al. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000392 · Cited by 1 · see citing works
Cognitive dysfunction in mice lacking proper glucocorticoid receptor dimerization
Looveren, K. V., Boxelaere, M. V., Callaerts‐Vegh, Z., & Libert, C. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.8.2
Li, Z., Zhu, M., Liu, Z., Hu, Q., Yang, J., Jin, Y., Zhu, N., Huang, Y., Shi, D., Liu, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1213529/v1
In-silico and in-vivo evaluation of comparative enhanced neurogenic performance by energy drinks
Das, S., Khan, I., Debnath, A., Singh, R., & Dhasmana, S. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.10822
Kim, H. R., Lee, Y.-J., Kim, T.-W., Lim, R.-N., Hwang, D. Y., Moffat, J. J., Kim, S., Seo, J.-W., & Ka, M. (2020) · Figshare · doi:10.6084/m9.figshare.13152013
Brivio, P., Palumbo, A., Gallo, M. T., Veronesi, F. U. T., Cortinovis, G., Gruca, P., Łasoń, M., Litwa, E., Biała, D., Fumagalli, F., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70594 · Cited by 1 · see citing works
- Authors
- Papp, M., Gruca, P., Lason-Tyburkiewicz, M., Litwa, E., Niemczyk, M., Tota-Glowczyk, K., & Willner, P.
- Affiliations
- Maj Institute of Pharmacology (PL)
- Swansea University (GB)
- Corresponding author
- Papp, Mariusz
- Venue
- Psychopharmacology
- Published
- 2017-05-31
- Volume
- 234
- Issue
- 17
- Pages
- 2571-2585
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC5548836
- OpenAlex
- W2616931289
- Cited by
- 40
- References
- 135
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 12 · 2019: 7 · 2018: 6
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Science Centre (NCN) (2013/09/B/NZ7/04098)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- dopaminergic mechanisms, memory consolidation, chronic mild stress, cognitive impairment, depression, novel object recognition, medial prefrontal cortex, dorsal hippocampus, nucleus accumbens shell, dopamine D1 receptor, dopamine D2 receptor, dopamine D3 receptor, venlafaxine, risperidone
- MeSH terms
- Memory Consolidation, Animals, Antidepressive Agents, Depression, Hippocampus, Male, Nucleus Accumbens, Stress, Psychological, Rats, Wistar, Prefrontal Cortex, Receptors, Dopamine D1, Receptors, Dopamine D2, Dopamine Agonists, Dopamine Antagonists, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review